Merck MRK
NYSE MRK
$145.57 +3.17 (+2.23%)
At close: Oct 9, 2026 · 4:00 PM EDT

Merck (MRK) Selling, General & Administrative (2009 - 2026)

Updated

Merck (MRK) recorded Selling, General & Administrative of $2.9 billion in Q2 2026, up 9.6% from $2.65 billion a year earlier and up 7.6% from the prior quarter.

Analysis

Merck (MRK) Selling, General & Administrative (2009 - 2026) Analysis & Trends

On a TTM basis, Merck's Selling, General & Administrative came in at $11.14 billion as of Jun 30, 2026, up 3.1% year-over-year; for FY2025, it was $10.73 billion, down 0.8% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 3.7% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $10.82 billion in FY2024 (+3.0%), $10.5 billion in FY2023 (+4.6%), $10.04 billion in FY2022 (+4.2%) and $9.63 billion in FY2021 (+7.6%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q4 2014.
  • On a year-over-year basis, Selling, General & Administrative has increased for three consecutive quarters, with growth averaging 2.9% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 13.4% in Q3 2021, against a decline of 5.1% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.7 billion (Q1 2026), $2.9 billion (Q4 2025) and $2.63 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 6.43 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 3.63 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -5.65 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 1.92 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 3.41 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 582.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.90 Bn
Mar 31, 2026 2.70 Bn
Dec 31, 2025 2.90 Bn
Sep 30, 2025 2.63 Bn
Jun 30, 2025 2.65 Bn
Mar 31, 2025 2.55 Bn
Dec 31, 2024 2.86 Bn
Sep 30, 2024 2.73 Bn
Jun 30, 2024 2.74 Bn
Mar 31, 2024 2.48 Bn
Dec 31, 2023 2.80 Bn
Sep 30, 2023 2.52 Bn
Jun 30, 2023 2.70 Bn
Mar 31, 2023 2.48 Bn
Dec 31, 2022 2.69 Bn
Sep 30, 2022 2.52 Bn
Jun 30, 2022 2.51 Bn
Mar 31, 2022 2.32 Bn
Dec 31, 2021 2.83 Bn
Sep 30, 2021 2.34 Bn
API Access

Merck Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MRK&period=max&api_key=YOUR_API_KEY